Invitrocue creates Joint Venture with A*STAR scientist Dr Chen Qingfeng

Pharma |  News | 0 Comment | 12 Feb, 2019

Invitrocue, a leading healthcare bio-analytic solutions provider, is pleased to announce the establishment of InvivoCue, a joint venture (JV) between Invitrocue and A*STAR scientist Dr. Che...Read more

Samsung Bioepis, C-Bridge Capital to develop next-gen biosimilars

Pharma |  News | 0 Comment | 12 Feb, 2019

Samsung Bioepis Co., Ltd. has announced its expansion in mainland China through a licensing agreement with C-Bridge Capital. The agreement covers multiple biosimilar candidates from Samsung...Read more

Glenmark receives ANDA approval for Sevelamer Hydrochloride Tablets

Pharma |  News | 0 Comment | 11 Feb, 2019

Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration for Sevelamer Hydrochloride Tablets, 400 mg and 800 mg, a generic version of Ren...Read more

Kyowa Hakko Kirin initiates Ph 2 Clinical Study of Tenapanor

Pharma |  News | 0 Comment | 08 Feb, 2019

Kyowa Hakko Kirin Co., Ltd. announced the initiation of a phase 2 clinical study in Japan for tenapanor, a small molecule compound licensed from Ardelyx, Inc. Tenapanor is an oral, mini...Read more

Eiger BioPharma gets patent protection for HDV drug in Europe and Japan

Pharma |  News | 0 Comment | 08 Feb, 2019

Eiger BioPharmaceuticals, Inc., focused on the development and commercialization of targeted therapies for rare and ultra-rare diseases, has announced that the European Patent Office and th...Read more

FDA approves Sanofi's blood disorder drug

Pharma |  News | 0 Comment | 07 Feb, 2019

The U.S. Food and Drug Administration (FDA) has approved Cablivi (caplacizumab-yhdp) in combination with plasma exchange and immunosuppression for the treatment of acquired thrombotic ...Read more

Roche & Chugai join WFH aid programme

Pharma |  News | 0 Comment | 07 Feb, 2019

Chugai Pharmaceutical has announced that Roche has joined the World Federation of Hemophilia (WFH) Humanitarian Aid Program, an initiative leading the effort to change the lack of acce...Read more

Glenmark Pharma signs an agreement with Grandpharma

Pharma |  News | 0 Comment | 07 Feb, 2019

Glenmark Pharmaceuticals Ltd. (Glenmark) has announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Grandpharma (China) Co. Ltd...Read more

GSK collaborates with Merck for cancer immunotherapy

Pharma |  News | 0 Comment | 06 Feb, 2019

GlaxoSmithKline and Merck KGaA, Darmstadt, Germany have announced that they have entered into a global strategic alliance to jointly develop and commercialise M7824 (bintrafusp alfa) M7824...Read more

Taiho Pharma teams up with Cullinan Oncology

Pharma |  News | 0 Comment | 05 Feb, 2019

Taiho Pharmaceutical and Cullinan Oncology, LLC announced an agreement to develop TAS6417, a novel EGFR (epidermal growth factor receptor) tyrosine kinase inhibitor discovered by Taiho Phar...Read more

BioLineRx announces underwritten public offering of its ADS

Pharma |  News | 0 Comment | 05 Feb, 2019

An Israel based BioLineRx Ltd., a clinical-stage biopharmaceutical company focused on oncology and immunology, has announced that it has commenced an underwritten public offering of America...Read more

Positive CHMP opinion for Chugai’s Hemlibra

Pharma |  News | 0 Comment | 04 Feb, 2019

Chugai Pharmaceutical  has announced that Roche has received notification that the EU Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for Hemlibra®...Read more

Fortress Biotech announces strategic partnership with Alexion Pharma

Pharma |  News | 0 Comment | 04 Feb, 2019

Biopharma company, Fortress Biotech dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products has announced that Caelum Biosciences has signed a...Read more

Alkermes announces rejection of ALKS 5461 NDA

Pharma |  News | 0 Comment | 04 Feb, 2019

Alkermes plc has announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ALKS 5461 for the ...Read more

Strides to exit investment in Arrow

Pharma |  News | 0 Comment | 04 Feb, 2019

Strides Pharma Science Limited (Strides) has announced that its step-down subsidiary Strides Pharma Global Pte, Limited, has approved the sale of its entire Australian business (Including A...Read more

J&J collaborates with MeiraGTx

Pharma |  News | 0 Comment | 01 Feb, 2019

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced a worldwide collaboration and license agreement with MeiraGTx Holdings, a clinical-stage gene therapy company, to...Read more

Hitachi to acquire apceth Biopharma

Pharma |  News | 0 Comment | 01 Feb, 2019

apceth Biopharma GmbH, a contract manufacturing organization in the field of cell and gene therapy has announced that Hitachi Chemical Co., Ltd. will enter into an agreement to acquire all ...Read more

I Holland to conduct seminar on problems in tablet production

Pharma |  News | 0 Comment | 31 Jan, 2019

I Holland, leaders in the manufacture of tablet tooling for the pharmaceutical and nutraceutical markets is pleased to announce that the company is hosting the ‘Ultimate Gui...Read more